|
US2642514A
(en)
|
1946-08-10 |
1953-06-16 |
American Cyanamid Co |
Ion exchange process with magnetic ion exchange resins
|
|
GB1239978A
(en)
|
1968-07-15 |
1971-07-21 |
Permutt Company Ltd |
Ion-exchange processes
|
|
US5650270A
(en)
|
1982-02-01 |
1997-07-22 |
Northeastern University |
Molecular analytical release tags and their use in chemical analysis
|
|
US5516931A
(en)
|
1982-02-01 |
1996-05-14 |
Northeastern University |
Release tag compounds producing ketone signal groups
|
|
US4709016A
(en)
|
1982-02-01 |
1987-11-24 |
Northeastern University |
Molecular analytical release tags and their use in chemical analysis
|
|
US4650750A
(en)
|
1982-02-01 |
1987-03-17 |
Giese Roger W |
Method of chemical analysis employing molecular release tag compounds
|
|
US5595756A
(en)
|
1993-12-22 |
1997-01-21 |
Inex Pharmaceuticals Corporation |
Liposomal compositions for enhanced retention of bioactive agents
|
|
US20020164788A1
(en)
|
1994-12-02 |
2002-11-07 |
The Wellcome Foundation Limited |
Humanized antibodies to CD38
|
|
AU725609C
(en)
|
1995-08-18 |
2002-01-03 |
Morphosys Ag |
Protein/(poly)peptide libraries
|
|
JP2001505194A
(ja)
|
1996-11-05 |
2001-04-17 |
ブリストル―マイヤーズ・スクイブ・カンパニー |
分枝ペプチド・リンカー
|
|
US6410275B1
(en)
|
1997-05-02 |
2002-06-25 |
Biomerieux, Inc. |
Disposable test devices for performing nucleic acid amplification reactions
|
|
US6326144B1
(en)
|
1998-09-18 |
2001-12-04 |
Massachusetts Institute Of Technology |
Biological applications of quantum dots
|
|
CA2345376C
(en)
|
1998-09-24 |
2010-03-16 |
Advanced Research And Technology Institute, Inc. |
Water-soluble luminescent quantum dots and bioconjugates thereof
|
|
US6927203B1
(en)
*
|
1999-08-17 |
2005-08-09 |
Purdue Research Foundation |
Treatment of metastatic disease
|
|
EP1382339B1
(en)
|
1999-12-10 |
2007-12-05 |
Pfizer Products Inc. |
Compositions containing pyrrolo ¬2,3-d pyrimidine derivatives
|
|
PE20020354A1
(es)
|
2000-09-01 |
2002-06-12 |
Novartis Ag |
Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
|
|
EP1389617B1
(en)
|
2001-04-27 |
2007-01-03 |
Zenyaku Kogyo Kabushiki Kaisha |
Heterocyclic compound and antitumor agent containing the same as active ingredient
|
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
|
DK3031910T3
(en)
|
2002-02-21 |
2017-10-23 |
Inst Virology |
MN / CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED BY MN / CA IX-DEFICIENT MOUSE AND METHODS OF USE
|
|
WO2004019973A1
(en)
|
2002-08-14 |
2004-03-11 |
Atugen Ag |
Use of protein kinase n beta
|
|
JP2006514104A
(ja)
|
2002-12-12 |
2006-04-27 |
テル アヴィヴ ユニヴァーシティ フューチャー テクノロジー ディヴェロップメント エル．ピー． |
グリコーゲンシンターゼキナーゼ−３阻害剤
|
|
EP1452868A2
(en)
|
2003-02-27 |
2004-09-01 |
Pepscan Systems B.V. |
Method for selecting a candidate drug compound
|
|
KR20070087266A
(ko)
|
2003-04-03 |
2007-08-28 |
세마포르 파머슈티컬즈, 아이엔씨. |
피아이-3 키나아제 억제제 프로드러그
|
|
CN1832939B
(zh)
|
2003-05-30 |
2010-04-28 |
杰明X医药品加拿大公司 |
用于治疗癌症或病毒病的三杂环化合物、组合物和方法
|
|
US7173015B2
(en)
|
2003-07-03 |
2007-02-06 |
The Trustees Of The University Of Pennsylvania |
Inhibition of Syk kinase expression
|
|
DK2511297T3
(en)
|
2004-02-06 |
2015-06-15 |
Morphosys Ag |
Human anti-CD38 antibodies and their applications
|
|
US7151047B2
(en)
|
2004-04-28 |
2006-12-19 |
Warren Chan |
Stable, water-soluble quantum dot, method of preparation and conjugates thereof
|
|
SI2612862T1
(sl)
|
2004-05-13 |
2017-04-26 |
Icos Corporation |
Kinazolini kot inhibitorji humane fosfatidilinozitol 3-kinaze delta
|
|
TWI309240B
(en)
|
2004-09-17 |
2009-05-01 |
Hoffmann La Roche |
Anti-ox40l antibodies
|
|
DE602006010979D1
(de)
|
2005-01-19 |
2010-01-21 |
Rigel Pharmaceuticals Inc |
Prodrugs aus 2,4-pyrimidindiamin-verbindungen und ihre verwendungen
|
|
DK1844337T3
(da)
|
2005-01-24 |
2013-09-30 |
Pepscan Systems Bv |
Bindingsforbindelser, immunogene forbindelser og peptidmimetika
|
|
KR101314899B1
(ko)
|
2005-03-22 |
2013-10-04 |
로도세이야구가부시기가이샤 |
콜라겐 또는 히알루론산 생성을 증가시키는 펩티드
|
|
AU2006230099B2
(en)
|
2005-03-25 |
2012-04-19 |
Gitr, Inc. |
GITR binding molecules and uses therefor
|
|
EP1888550B1
(en)
|
2005-05-12 |
2014-06-25 |
AbbVie Bahamas Ltd. |
Apoptosis promoters
|
|
GB0510390D0
(en)
|
2005-05-20 |
2005-06-29 |
Novartis Ag |
Organic compounds
|
|
CN104356236B
(zh)
|
2005-07-01 |
2020-07-03 |
E.R.施贵宝&圣斯有限责任公司 |
抗程序性死亡配体1(pd-l1)的人单克隆抗体
|
|
US7402325B2
(en)
|
2005-07-28 |
2008-07-22 |
Phoenix Biotechnology, Inc. |
Supercritical carbon dioxide extract of pharmacologically active components from Nerium oleander
|
|
US20090304721A1
(en)
|
2005-09-07 |
2009-12-10 |
Medlmmune, Inc |
Toxin conjugated eph receptor antibodies
|
|
BRPI0617162B8
(pt)
|
2005-10-07 |
2021-05-25 |
Exelixis Inc |
compostos inibidores de fosfatidilinositol 3-quinase composições farmacêuticas que os contem e métodos de uso dos mesmos
|
|
CN103626742B
(zh)
|
2005-11-01 |
2017-04-26 |
塔格根公司 |
激酶的联-芳基间-嘧啶抑制剂
|
|
EP2455382B1
(en)
|
2005-12-13 |
2016-10-26 |
Incyte Holdings Corporation |
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
|
|
JO2660B1
(en)
|
2006-01-20 |
2012-06-17 |
نوفارتيس ايه جي |
Pi-3 inhibitors and methods of use
|
|
WO2007093836A1
(en)
|
2006-02-13 |
2007-08-23 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from a xp gene and uses thereof
|
|
MX2008013578A
(es)
|
2006-04-26 |
2009-03-23 |
Hoffmann La Roche |
Derivados de tieno [3,2-d]pirimidina utiles como inhibidores de fosfatidilinositol 3-cinasa(p13k).
|
|
EP2061519B1
(en)
|
2006-09-15 |
2016-03-30 |
Siemens Medical Solutions USA, Inc. |
Click chemistry-derived cyclopeptide derivatives as imaging agents for integrins
|
|
BRPI0622054B8
(pt)
|
2006-09-22 |
2021-05-25 |
Oxford Amherst Llc |
composto e composição farmacêutica
|
|
CN101232326B
(zh)
|
2007-01-22 |
2012-01-11 |
中兴通讯股份有限公司 |
用于无源光网络系统的动态带宽分配装置及其实现方法
|
|
HRP20151386T1
(hr)
|
2007-03-12 |
2016-02-26 |
Ym Biosciences Australia Pty Ltd |
Fenil aminopirimidinski spojevi i njihova primjena
|
|
WO2008118802A1
(en)
|
2007-03-23 |
2008-10-02 |
Regents Of The University Of Minnesota |
Therapeutic compounds
|
|
EP1987839A1
(en)
|
2007-04-30 |
2008-11-05 |
I.N.S.E.R.M. Institut National de la Sante et de la Recherche Medicale |
Cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease
|
|
US20090110662A1
(en)
|
2007-04-30 |
2009-04-30 |
Intezyne Technologies, Inc. |
Modification of biological targeting groups for the treatment of cancer
|
|
PE20090717A1
(es)
|
2007-05-18 |
2009-07-18 |
Smithkline Beecham Corp |
Derivados de quinolina como inhibidores de la pi3 quinasa
|
|
US20100254996A1
(en)
|
2007-06-18 |
2010-10-07 |
Medimmune, Llc |
Synergistic treatment of cells that express epha2 and erbb2
|
|
ES2776406T3
(es)
|
2007-07-12 |
2020-07-30 |
Gitr Inc |
Terapias de combinación que emplean moléculas de enlazamiento a GITR
|
|
EP2044949A1
(en)
|
2007-10-05 |
2009-04-08 |
Immutep |
Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response
|
|
JP5583592B2
(ja)
|
2007-11-30 |
2014-09-03 |
ニューリンク ジェネティクス コーポレイション |
Ｉｄｏ阻害剤
|
|
CN101497878B
(zh)
|
2008-01-30 |
2012-11-07 |
房学迅 |
特异性高效亲和膜ⅰ型基质金属蛋白酶(mt1-mmp)的多肽、蛋白及其应用
|
|
WO2009097397A2
(en)
|
2008-01-30 |
2009-08-06 |
Dyax Corp. |
Metalloproteinase binding proteins
|
|
AU2009211253B2
(en)
|
2008-02-05 |
2014-11-06 |
Bicyclerd Limited |
Methods and compositions
|
|
AU2009219682B2
(en)
|
2008-02-27 |
2015-06-18 |
Yeda Research & Development Co. Ltd |
RGD-(bacterio)chlorophyll conjugates for photodynamic therapy and imaging of necrotic tumors
|
|
US8158616B2
(en)
|
2008-03-11 |
2012-04-17 |
Incyte Corporation |
Azetidine and cyclobutane derivatives as JAK inhibitors
|
|
US8293714B2
(en)
|
2008-05-05 |
2012-10-23 |
Covx Technology Ireland, Ltd. |
Anti-angiogenic compounds
|
|
FR2932189A1
(fr)
|
2008-06-10 |
2009-12-11 |
Commissariat Energie Atomique |
Biopuces pour la detection de l'activite enzymatique d'une enzyme protease
|
|
US8338439B2
(en)
|
2008-06-27 |
2012-12-25 |
Celgene Avilomics Research, Inc. |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
|
US8834926B2
(en)
|
2008-08-08 |
2014-09-16 |
University Of Delaware |
Macromolecular diffusion and release from self-assembled β-hairpin peptide hydrogels
|
|
AR072999A1
(es)
|
2008-08-11 |
2010-10-06 |
Medarex Inc |
Anticuerpos humanos que se unen al gen 3 de activacion linfocitaria (lag-3) y los usos de estos
|
|
AU2009333580B2
(en)
|
2008-12-09 |
2016-07-07 |
Genentech, Inc. |
Anti-PD-L1 antibodies and their use to enhance T-cell function
|
|
GB0913775D0
(en)
|
2009-08-06 |
2009-09-16 |
Medical Res Council |
Multispecific peptides
|
|
AU2010249719A1
(en)
|
2009-05-19 |
2012-05-31 |
Aic Blab Company |
Composite current collector and methods therefor
|
|
GB0914110D0
(en)
|
2009-08-12 |
2009-09-16 |
Medical Res Council |
Peptide libraries
|
|
EP2473531A4
(en)
|
2009-09-03 |
2013-05-01 |
Merck Sharp & Dohme |
Anti-gitr antibodies
|
|
US8722720B2
(en)
|
2009-10-28 |
2014-05-13 |
Newlink Genetics Corporation |
Imidazole derivatives as IDO inhibitors
|
|
WO2011063366A1
(en)
|
2009-11-23 |
2011-05-26 |
Palatin Technologies, Inc. |
Melanocortin-1 receptor-specific cyclic peptides
|
|
PH12012500881A1
(en)
|
2009-12-10 |
2017-07-26 |
Hoffmann La Roche |
Antibodies binding preferentially human csf1r extracellular domain 4 and their use
|
|
WO2011079015A1
(en)
|
2009-12-21 |
2011-06-30 |
The Regents Of The University Of California |
Rgd-containing cyclic peptides
|
|
EP2343081A1
(en)
|
2009-12-31 |
2011-07-13 |
Rijksuniversiteit Groningen |
Interferon analogs
|
|
JP2013518807A
(ja)
|
2010-02-04 |
2013-05-23 |
メディカル リサーチ カウンシル |
多重特異性ペプチド
|
|
JP5998060B2
(ja)
|
2010-03-04 |
2016-09-28 |
マクロジェニクス，インコーポレーテッド |
Ｂ７−ｈ３と反応性のある抗体、その免疫学的に活性なフラグメントおよびその使用
|
|
CN102918061B
(zh)
|
2010-03-05 |
2016-06-08 |
霍夫曼-拉罗奇有限公司 |
针对人csf-1r的抗体及其用途
|
|
CA2789076C
(en)
|
2010-03-05 |
2017-11-21 |
F. Hoffmann-La Roche Ag |
Antibodies against human colony stimulating factor-1 receptor and uses thereof
|
|
MX378336B
(es)
|
2010-05-04 |
2025-03-10 |
Five Prime Therapeutics Inc |
Anticuerpos que se unen a factor estimulante de colonias 1 (csf1r).
|
|
PT2614082T
(pt)
|
2010-09-09 |
2018-12-03 |
Pfizer |
Moléculas de ligação a 4-1bb
|
|
WO2012057624A1
(en)
|
2010-10-25 |
2012-05-03 |
Pepscan Systems B.V. |
Novel bicyclic peptide mimetics
|
|
PH12013501201A1
(en)
|
2010-12-09 |
2013-07-29 |
Univ Pennsylvania |
Use of chimeric antigen receptor-modified t cells to treat cancer
|
|
US20130072598A1
(en)
|
2011-03-18 |
2013-03-21 |
Board Of Regents Of The University Of Nebraska |
Thermoplastics from Distillers Dried Grains and Feathers
|
|
NO2694640T3
(https=)
|
2011-04-15 |
2018-03-17 |
|
|
|
KR101970025B1
(ko)
|
2011-04-20 |
2019-04-17 |
메디뮨 엘엘씨 |
Ｂ7-ｈ1 및 ｐｄ-1과 결합하는 항체 및 다른 분자들
|
|
AU2012320407B2
(en)
|
2011-10-07 |
2017-04-20 |
Bicyclerd Limited |
Modulation of structured polypeptide specificity
|
|
GB201117428D0
(en)
|
2011-10-07 |
2011-11-23 |
Bicycle Therapeutics Ltd |
Structured polypeptides with sarcosine linkers
|
|
HRP20201595T1
(hr)
|
2011-11-28 |
2020-12-11 |
Merck Patent Gmbh |
Anti-pd-l1 protutijela i njihova uporaba
|
|
BR112014012624A2
(pt)
|
2011-12-15 |
2018-10-09 |
F Hoffmann-La Roche Ag |
anticorpos, composição farmacêutica, ácido nucleico, vetores de expressão, célula hospedeira, método para a produção de um anticorpo recombinante e uso do anticorpo
|
|
RU2014136332A
(ru)
|
2012-02-06 |
2016-03-27 |
Дженентек, Инк. |
Композиции и способы применения ингибиторов csf1r
|
|
AR090263A1
(es)
|
2012-03-08 |
2014-10-29 |
Hoffmann La Roche |
Terapia combinada de anticuerpos contra el csf-1r humano y las utilizaciones de la misma
|
|
EP2847220A1
(en)
|
2012-05-11 |
2015-03-18 |
Five Prime Therapeutics, Inc. |
Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (csf1r)
|
|
AR091649A1
(es)
|
2012-07-02 |
2015-02-18 |
Bristol Myers Squibb Co |
Optimizacion de anticuerpos que se fijan al gen de activacion de linfocitos 3 (lag-3) y sus usos
|
|
CN107759690A
(zh)
|
2012-08-31 |
2018-03-06 |
戊瑞治疗有限公司 |
用结合群落刺激因子1受体(csf1r)的抗体治疗病状的方法
|
|
SG10201702387YA
(en)
|
2012-09-24 |
2017-04-27 |
Medimmune Ltd |
Cell lines
|
|
WO2014063012A1
(en)
|
2012-10-19 |
2014-04-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Conjugated knottin mini-proteins containing non-natural amino acids
|
|
US9790286B2
(en)
*
|
2013-01-02 |
2017-10-17 |
Lucia Irene Gonzalez |
Stereoisomer peptides, their polymer conjugates, their encapsulation into nanoparticles, and uses thereof for the treatment of diseases caused by abnormal angiogenesis
|
|
RS60280B1
(sr)
|
2013-03-12 |
2020-06-30 |
Molecular Templates Inc |
Citotoksični proteini koji sadrže ciljane vezujuće regione za ćelije i regioni shiga toksina a podjedinice za selektivno ubijanje određenih vrsta ćelija
|
|
US20140274759A1
(en)
|
2013-03-15 |
2014-09-18 |
Bicycle Therapeutics Limited |
Modification of polypeptides
|
|
WO2014142237A1
(ja)
|
2013-03-15 |
2014-09-18 |
日本ゼオン株式会社 |
中空重合体粒子の水性分散液およびその製造方法
|
|
WO2014146575A1
(en)
|
2013-03-19 |
2014-09-25 |
Beijing Shenogen Pharma Group Ltd. |
Antibodies and methods for treating estrogen receptor-associated diseases
|
|
GB201306623D0
(en)
|
2013-04-11 |
2013-05-29 |
Bicycle Therapeutics Ltd |
Modulation of structured polypeptide specificity
|
|
ES2705068T3
(es)
|
2013-05-23 |
2019-03-21 |
Ohio State Innovation Foundation |
Síntesis química y cribado de bibliotecas de péptidos bicíclicos
|
|
EP3024472A4
(en)
|
2013-07-22 |
2017-06-28 |
Kineta One, LLC |
Ophthalmic uses of toxin-based therapeutic peptides and pharmaceutical compositions thereof
|
|
CA2925106C
(en)
|
2013-09-25 |
2023-11-14 |
Cytomx Therapeutics, Inc. |
Matrix metalloproteinase substrates and other cleavable moieties and methods of use thereof
|
|
CN105683211B
(zh)
|
2013-10-28 |
2020-10-20 |
拜斯科阿迪有限公司 |
新型多肽
|
|
EP3102576B8
(en)
|
2014-02-03 |
2019-06-19 |
Vitae Pharmaceuticals, LLC |
Dihydropyrrolopyridine inhibitors of ror-gamma
|
|
DK3140653T3
(da)
|
2014-05-08 |
2022-06-20 |
Novodiax Inc |
Direkte immunhistokemianalyse
|
|
EP3613426A1
(en)
|
2014-05-21 |
2020-02-26 |
Entrada Therapeutics, Inc. |
Cell penetrating peptides and methods of making and using thereof
|
|
GB201416960D0
(en)
|
2014-09-25 |
2014-11-12 |
Antikor Biopharma Ltd |
Biological materials and uses thereof
|
|
JP6917887B2
(ja)
|
2014-09-30 |
2021-08-11 |
ポリフォー・アクチェンゲゼルシャフトＰｏｌｙｐｈｏｒ Ａｇ |
ベータ−ヘアピンペプチド模倣体
|
|
CA2963556C
(en)
|
2014-10-24 |
2023-03-14 |
Research Corporation Technologies, Inc. |
Small antibody-like polypeptides that bind to epha2 receptor
|
|
JP6882978B2
(ja)
|
2014-10-29 |
2021-06-02 |
バイスクルアールディー・リミテッド |
Ｍｔ１−ｍｍｐに特異的な二環性ペプチドリガンド
|
|
EP3212668B1
(en)
|
2014-10-31 |
2020-10-14 |
AbbVie Biotherapeutics Inc. |
Anti-cs1 antibodies and antibody drug conjugates
|
|
WO2016090157A1
(en)
|
2014-12-04 |
2016-06-09 |
Celgene Corporation |
Biomolecule conjugates
|
|
IL237525A
(en)
|
2015-03-03 |
2017-05-29 |
Shalom Eli |
Method for labeling a prostate-specific membrane antigen with a radioactive isotope
|
|
TW201707660A
(zh)
|
2015-04-22 |
2017-03-01 |
三井化學股份有限公司 |
設有關節用支撐部的衣類及膝用支撐物
|
|
WO2016171242A1
(ja)
|
2015-04-24 |
2016-10-27 |
第一三共株式会社 |
Ｅｐｈａ２の検出
|
|
JP2018521960A
(ja)
|
2015-04-28 |
2018-08-09 |
エコール・ポリテクニーク・フェデラル・ドゥ・ローザンヌ（ウペエフエル）Ｅｃｏｌｅ Ｐｏｌｙｔｅｃｈｎｉｑｕｅ Ｆｅｄｅｒａｌｅ ｄｅ Ｌａｕｓａｎｎｅ （ＥＰＦＬ） |
酵素で活性化された第ＸＩＩ因子（ＦＸＩＩａ）の新規阻害剤
|
|
EP3292222B1
(en)
|
2015-05-06 |
2025-09-03 |
Janssen Biotech, Inc. |
Prostate specific membrane antigen binding fibronectin type iii domains
|
|
MX390894B
(es)
*
|
2015-05-18 |
2025-03-21 |
Pieris Pharmaceuticals Gmbh |
Polipéptido de fusión anti-cáncer.
|
|
EP3115066A1
(en)
|
2015-07-07 |
2017-01-11 |
Technische Universität München |
Novel psma-specific binding proteins
|
|
US9963495B2
(en)
|
2015-10-27 |
2018-05-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Polypeptides targeting vascular endothelial growth factor receptor and prostate specific membrane antigen
|
|
EP3181146A1
(en)
|
2015-12-16 |
2017-06-21 |
Ruprecht-Karls-Universität Heidelberg |
Cyclic ntcp-targeting peptides and their uses as entry inhibitors
|
|
GB201600911D0
(en)
|
2016-01-18 |
2016-03-02 |
Bicycle Therapeutics Ltd |
Stabilized peptide derivatives
|
|
US10765625B2
(en)
|
2016-03-15 |
2020-09-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Knottin-drug conjugates and methods of using the same
|
|
US20190298681A1
(en)
|
2016-03-16 |
2019-10-03 |
Merrimack Pharmaceuticals, Inc. |
Nanoliposomal Targeting of Ephrin Receptor A2 (Epha2) and Related Diagnostics
|
|
JP2019513371A
(ja)
|
2016-04-01 |
2019-05-30 |
アビディティー バイオサイエンシーズ エルエルシー |
核酸ポリペプチド組成物とその使用
|
|
CA3016172C
(en)
*
|
2016-04-20 |
2024-03-12 |
Hangzhou Dac Biotech Co., Ltd |
Derivatives of amanita toxins and their conjugation to a cell binding molecule
|
|
AU2017252233A1
(en)
*
|
2016-04-22 |
2018-11-15 |
Alligator Bioscience Ab |
Novel bispecific polypeptides against CD137
|
|
GB201607827D0
(en)
|
2016-05-04 |
2016-06-15 |
Bicycle Therapeutics Ltd |
Bicyclic peptide-toxin conjugates specific for MT1-MMP
|
|
BR112018074453A2
(pt)
|
2016-05-27 |
2019-03-19 |
Abbvie Biotherapeutics Inc. |
proteínas de ligação biespecíficas ligando uma protéina imunomoduladora e um antígeno tumoral
|
|
US10441663B2
(en)
|
2016-11-27 |
2019-10-15 |
Bicyclerd Limited |
Methods for treating cancer
|
|
JP7387440B2
(ja)
|
2016-12-23 |
2023-11-28 |
バイスクルテクス・リミテッド |
Ｍｔ１－ｍｍｐに結合するためのペプチドリガンド
|
|
WO2018115203A1
(en)
|
2016-12-23 |
2018-06-28 |
Bicyclerd Limited |
Peptide derivatives having novel linkage structures
|
|
EP3565638B8
(en)
|
2017-01-06 |
2024-04-10 |
BicycleRD Limited |
Bicycle conjugate for treating cancer
|
|
IL268836B2
(en)
|
2017-02-24 |
2024-04-01 |
Macrogenics Inc |
Bispecific binding molecules that are capable of binding cd137 and tumor antigens, and uses thereof
|
|
GB201706477D0
(en)
|
2017-04-24 |
2017-06-07 |
Bicycle Therapeutics Ltd |
Modification of polypeptides
|
|
WO2018197893A1
(en)
|
2017-04-27 |
2018-11-01 |
Bicycletx Limited |
Bicyclic peptide ligands and uses thereof
|
|
WO2018222987A1
(en)
|
2017-06-01 |
2018-12-06 |
Tarveda Therapeutics, Inc. |
Targeted constructs
|
|
JP7301757B2
(ja)
|
2017-06-26 |
2023-07-03 |
バイスクルアールディー・リミテッド |
検出可能部分を持つ二環式ペプチドリガンドおよびその使用
|
|
CN111183147B
(zh)
|
2017-08-04 |
2024-07-05 |
拜斯科技术开发有限公司 |
Cd137特异性的双环肽配体
|
|
WO2019034866A1
(en)
|
2017-08-14 |
2019-02-21 |
Bicyclerd Limited |
BICYCLIC PEPTIDE LIGANDS CONJUGATES AND USES THEREOF
|
|
WO2019034868A1
(en)
|
2017-08-14 |
2019-02-21 |
Bicyclerd Limited |
CONJUGATES PEPTIDE BICYCLIC-LIGAND PPR-A AND USES THEREOF
|
|
WO2019084060A1
(en)
|
2017-10-24 |
2019-05-02 |
Silverback Therapeutics, Inc. |
CONJUGATES AND METHODS OF USE FOR THE SELECTIVE DELIVERY OF IMMUNOMODULATORY AGENTS
|
|
MX2020004691A
(es)
|
2017-11-07 |
2020-08-20 |
Regeneron Pharma |
Enlazadores hidrofilicos para conjugados anticuerpo-farmaco.
|
|
TWI825046B
(zh)
|
2017-12-19 |
2023-12-11 |
英商拜西可泰克斯有限公司 |
Epha2特用之雙環胜肽配位基
|
|
GB201721265D0
(en)
|
2017-12-19 |
2018-01-31 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for EphA2
|
|
US11572370B2
(en)
|
2018-01-08 |
2023-02-07 |
Biohaven Therapeutics Ltd. |
CD16A binding agents and uses thereof
|
|
JP2021514953A
(ja)
|
2018-02-23 |
2021-06-17 |
バイスクルテクス・リミテッド |
多量体二環式ペプチドリガンド
|
|
JP7551500B2
(ja)
|
2018-04-04 |
2024-09-17 |
バイスクルテクス・リミテッド |
ヘテロタンデム二環式ペプチド複合体
|
|
CA3099308A1
(en)
|
2018-05-21 |
2019-11-28 |
Compass Therapeutics Llc |
Compositions and methods for enhancing the killing of target cells by nk cells
|
|
GB201810320D0
(en)
|
2018-06-22 |
2018-08-08 |
Bicycletx Ltd |
Peptide ligands for binding to CD38
|
|
IL279489B2
(en)
|
2018-06-22 |
2025-10-01 |
Bicycletx Ltd |
Bicyclic peptide ligands specific for nectin-4, a drug conjugate containing the peptide ligands and a pharmaceutical composition containing the drug conjugate
|
|
GB201810325D0
(en)
|
2018-06-22 |
2018-08-08 |
Bicycletx Ltd |
Peptide ligands for binding to PSMA
|
|
GB201810329D0
(en)
|
2018-06-22 |
2018-08-08 |
Bicycletx Ltd |
Peptide ligands for binding to integrin avB3
|
|
GB201810327D0
(en)
|
2018-06-22 |
2018-08-08 |
Bicycletx Ltd |
Peptide ligands for binding to IL-17
|
|
GB201810316D0
(en)
|
2018-06-22 |
2018-08-08 |
Bicyclerd Ltd |
Peptide ligands for binding to EphA2
|
|
WO2020084305A1
(en)
|
2018-10-23 |
2020-04-30 |
Bicycletx Limited |
Bicyclic peptide ligands and uses thereof
|
|
CA3116504A1
(en)
|
2018-10-30 |
2020-05-07 |
Bicyclerd Limited |
Bt1718 for use in treating cancer
|
|
CA3122669A1
(en)
|
2018-12-13 |
2020-06-18 |
Bicycletx Limited |
Bicyclic peptide ligands specific for mt1-mmp
|
|
GB201820288D0
(en)
|
2018-12-13 |
2019-01-30 |
Bicycle Tx Ltd |
Bicycle peptide ligaands specific for MT1-MMP
|
|
GB201820325D0
(en)
|
2018-12-13 |
2019-01-30 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for psma
|
|
GB201820295D0
(en)
|
2018-12-13 |
2019-01-30 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for MT1-MMP
|
|
CA3120800A1
(en)
|
2018-12-17 |
2020-06-25 |
Revitope Limited |
Twin immune cell engager
|
|
JP2022514618A
(ja)
|
2018-12-21 |
2022-02-14 |
バイスクルテクス・リミテッド |
Ｐｄ－ｌ１に特異的な二環式ペプチドリガンド
|
|
US12551567B2
(en)
|
2018-12-21 |
2026-02-17 |
Bicyclerd Limited |
Bicyclic peptide ligands specific for PD-L1
|
|
US10882987B2
(en)
|
2019-01-09 |
2021-01-05 |
Nova Chemicals (International) S.A. |
Ethylene interpolymer products having intermediate branching
|
|
GB201900528D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for integrin AVB3
|
|
GB201900529D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicycletx Ltd |
Bicyclic peptide ligands specific for CD38
|
|
GB201900530D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for CD38
|
|
GB201900527D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicycletx Ltd |
Bicyclic peptide ligands specific for integrin avb3
|
|
GB201900525D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicycletx Ltd |
Bicyclic peptide ligands specific for caix
|
|
GB201900526D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for caix
|
|
WO2020165600A1
(en)
|
2019-02-14 |
2020-08-20 |
Bicycletx Limited |
Bicyclic peptide ligand sting conjugates and uses thereof
|
|
EP3935069A1
(en)
|
2019-03-04 |
2022-01-12 |
Bicyclerd Limited |
Synthesis of bicycle toxin conjugates, and intermediates thereof
|
|
US20220184222A1
(en)
|
2019-04-02 |
2022-06-16 |
Bicycletx Limited |
Bicycle toxin conjugates and uses thereof
|
|
KR20220007098A
(ko)
|
2019-05-09 |
2022-01-18 |
바이사이클티엑스 리미티드 |
Ox40에 특이적인 이환식 펩티드 리간드
|
|
TWI869398B
(zh)
|
2019-05-10 |
2025-01-11 |
英商拜西克爾德有限公司 |
治療癌症之方法
|
|
TWI860386B
(zh)
|
2019-07-30 |
2024-11-01 |
英商拜西可泰克斯有限公司 |
異質雙環肽複合物
|
|
WO2021028686A1
(en)
|
2019-08-13 |
2021-02-18 |
Bicycletx Limited |
Modified multimeric bicyclic peptide ligands
|
|
GB201912320D0
(en)
|
2019-08-28 |
2019-10-09 |
Bicycletx Ltd |
PBP Binding Bicyclic Peptide Ligands
|
|
ES3033517T3
(en)
|
2019-10-03 |
2025-08-05 |
Bicycletx Ltd |
Heterotandem bicyclic peptide complexes
|
|
GB201914872D0
(en)
|
2019-10-15 |
2019-11-27 |
Bicycletx Ltd |
Bicyclic peptide ligand drug conjugates
|
|
US20220387611A1
(en)
|
2019-10-16 |
2022-12-08 |
Bicyclerd Limited |
Methods for treating cancer
|
|
CN114760988A
(zh)
|
2019-11-27 |
2022-07-15 |
拜斯科技术开发有限公司 |
对EphA2具有特异性的双环肽配体和其用途
|
|
IT202000001231A1
(it)
|
2020-01-22 |
2021-07-22 |
Celery S R L |
Nuovi ceppi di batteri lattici, composizione alimentare che li comprende, preparazione di tale composizione
|
|
GB202002706D0
(en)
|
2020-02-26 |
2020-04-08 |
Bicycletx Ltd |
Pbp3 binding bicyclic peptide ligands
|
|
GB202002705D0
(en)
|
2020-02-26 |
2020-04-08 |
Bicycletx Ltd |
Anti-infective bicyclic peptide conjugates
|
|
KR20230037502A
(ko)
|
2020-05-20 |
2023-03-16 |
바이사이클티엑스 리미티드 |
넥틴-4에 특이적인 바이사이클릭 펩티드 리간드 및 이의 용도
|
|
EP4165414A1
(en)
|
2020-06-12 |
2023-04-19 |
BicycleTX Limited |
Treatment of diseases characterized by overexpression of erythropoietin-producing hepatocellular receptor a2 (epha2)
|
|
IL300248A
(en)
|
2020-08-03 |
2023-03-01 |
Bicycletx Ltd |
peptide-based linkers
|
|
WO2022038158A1
(en)
|
2020-08-17 |
2022-02-24 |
Bicycletx Limited |
Bicycle conjugates specific for nectin-4 and uses thereof
|
|
AU2022206394A1
(en)
|
2021-01-08 |
2023-08-24 |
Bicycletx Limited |
Bicyclic peptide ligands specific for nk cells
|
|
KR20230141794A
(ko)
|
2021-01-08 |
2023-10-10 |
바이사이클티엑스 리미티드 |
헤테로탠덤 바이사이클릭 펩티드 복합체
|
|
CN117157305A
(zh)
|
2021-01-08 |
2023-12-01 |
拜斯科技术开发有限公司 |
抗感染的双环肽配体
|
|
US20250186539A2
(en)
|
2021-01-11 |
2025-06-12 |
Bicycletx Limited |
Methods for treating cancer
|
|
AU2022340959A1
(en)
|
2021-09-03 |
2024-03-07 |
Bicycletx Limited |
Synthesis of bicycle toxin conjugates, and intermediates thereof
|
|
AU2022390670A1
(en)
|
2021-11-16 |
2024-05-23 |
Bicycletx Limited |
Methods for treating cancer
|